Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVDTK.L Regulatory News (VDTK)

  • There is currently no data for VDTK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Sep 2020 07:00

RNS Number : 5369Y
Verditek PLC
10 September 2020
 

Verditek plc

Issue of Equity on Conversion of Convertible Loan Note and Settlement of Adviser Fees

 

Verditek plc ("Verditek" or "Company"), the international clean technology company that develops, manufactures and sells certified lightweight solar panels, announces that it has received a notice of conversion of£100,000 of convertible loan notes ("CLN's") at 10 pence per share. This, together with accrued interest, means 1,184,544 new ordinary shares are due to be issued. There remains a balance of issued CLN's of £70,000. In addition, the company has allotted 590,909 new ordinary shares in settlement of PR adviser fees.

Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will occur at 8.00 a.m. on 15 September 2020. The new ordinary shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after the admission of the new ordinary shares, and will otherwise be identical to and rank pari passu in all respects with the existing ordinary shares.

Following Admission of the 1,775,453 new ordinary shares, Verditek will have 297,422,443 ordinary shares in issue and admitted to trading on AIM. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

Enquiries:

Verditek plc

RH Lord David Willetts FRS (Non-Executive Chairman)

Rob Richards (Chief Executive Officer)

 

 

Tel: +44 (0)20 7129 1110enquiries@verditek.plc.uk

 

WH Ireland Limited (NOMAD and Broker)

 

 

Tel: +44 (0)20 7220 1666

Chris Hardie (Corporate Finance)

Matthew Chan

 

 

About Verditek plc

AIM listed Verditek plc is a holding company with three businesses operating within the clean technology sector. The Company is focused on commercializing our lightweight low-profile solar panel business. With manufacturing based in Lainate Italy, we have developed renewable power solutions for our customers that drive solar energy into applications previously impossible. The exceptional properties of our solar panels replace diesel fuel in business such as perishable goods transport, off-grid telecommunication towers, electric vehicle charging stations, residential and holiday home power solutions and solar roofing for light-weight industrial roofing. In addition to our current PV panels in production, we have partnered with an outstanding leader in graphene technology, Paragraf, and have created the worlds' first Graphene Integrated Photo Voltaic cell. We are working together to engineer the technology for commercialization.

 

Verditek provides compelling commercial solutions that make our customers business sustainable.

 

For more information please visit or contact the following: https://verditek.com/

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUPUGCBUPUGQB
Date   Source Headline
6th Mar 20244:18 pmRNSHolding(s) in Company
6th Mar 20242:35 pmRNSHolding(s) in Company
6th Mar 20241:22 pmRNSHolding(s) in Company
6th Mar 20241:16 pmRNSHolding(s) in Company
6th Mar 202412:13 pmRNSHolding(s) in Company
6th Mar 20248:55 amRNSChange of Name Effective
5th Mar 20245:07 pmRNSHolding(s) in Company
5th Mar 20244:20 pmRNSHolding(s) in Company
5th Mar 20248:05 amRNSAdmission of Shares, Director Shareholding & TVR
1st Mar 20248:37 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSCompletion, Update and Appointment of Advisers
28th Feb 20243:07 pmRNSResult of General Meeting
28th Feb 20247:00 amRNSProposed Disposal, board changes and fundraising
23rd Feb 202410:31 amRNSReplacement: Update on the Proposed Disposal
23rd Feb 20247:00 amRNSUpdate on the Proposed Disposal
21st Feb 20244:11 pmRNSHolding(s) in Company
15th Feb 202412:43 pmRNSHolding(s) in Company
9th Feb 202410:05 amRNSNotice of General Meeting
7th Feb 20247:00 amRNSProposed Disposal
31st Jan 20244:12 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSHolding(s) in Company
9th Jan 20243:17 pmRNSHolding(s) in Company
8th Jan 20243:50 pmRNSHolding(s) in Company
5th Jan 20243:55 pmRNSHolding(s) in Company
2nd Jan 20243:17 pmRNSResignation of Director
22nd Dec 20237:00 amRNSAdjournment of General Meeting
4th Dec 20237:00 amRNSNotice of General Meeting
29th Nov 20239:02 amRNSFinancing Update
29th Sep 20237:00 amRNSInterim Report for six months to 30 June 2023
8th Sep 20235:15 pmRNSHolding(s) in Company
7th Sep 20234:07 pmRNSHolding(s) in Company
1st Sep 20237:00 amRNSSubscription of Ordinary Shares to raise £500,000
15th Aug 20237:00 amRNSMOU Signed with Net Zero Valley
25th Jul 20233:39 pmRNSResults of 2023 Annual General Meeting
29th Jun 20237:00 amRNSFinal Audited Results
18th May 20237:00 amRNSChange of Registered Office Address
3rd May 20231:12 pmRNSIssue of Secured Convertible Loan Notes 2025
28th Mar 20237:00 amRNSOrder from Roof Tile Group, Belgium
22nd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSSupply Agreement with Lindab Profil AB
20th Feb 20237:00 amRNSVerditek & Bradclad Distribution Agreement Update
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
11th Jan 20232:05 pmRNSSecond Price Monitoring Extn
11th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Oct 20224:07 pmRNSTR1: Notification of Major Holdings
19th Oct 202211:06 amRNSSecond Price Monitoring Extn
19th Oct 202211:00 amRNSPrice Monitoring Extension
19th Oct 20227:00 amRNSVerditek and Bradclad Distribution Agreement
16th Sep 20227:32 amRNSTR1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.